Sarepta Therapeutics, Inc. (SRPT): Price and Financial Metrics
GET POWR RATINGS... FREE!
SRPT POWR Grades
- SRPT scores best on the Quality dimension, with a Quality rank ahead of 71.46% of US stocks.
- SRPT's strongest trending metric is Quality; it's been moving up over the last 179 days.
- SRPT's current lowest rank is in the Sentiment metric (where it is better than 20.61% of US stocks).
SRPT Stock Summary
- SRPT has a higher market value than 84.21% of US stocks; more precisely, its current market capitalization is $10,970,188,523.
- Of note is the ratio of SAREPTA THERAPEUTICS INC's sales and general administrative expense to its total operating expenses; just 15.29% of US stocks have a lower such ratio.
- SRPT's price/sales ratio is 12.52; that's higher than the P/S ratio of 90.7% of US stocks.
- If you're looking for stocks that are quantitatively similar to SAREPTA THERAPEUTICS INC, a group of peers worth examining would be ONCT, SLDP, UBX, STRO, and EXAI.
- SRPT's SEC filings can be seen here. And to visit SAREPTA THERAPEUTICS INC's official web site, go to www.sarepta.com.
SRPT Valuation Summary
- In comparison to the median Healthcare stock, SRPT's price/sales ratio is 137.25% higher, now standing at 12.1.
- SRPT's price/sales ratio has moved down 105.4 over the prior 243 months.
Below are key valuation metrics over time for SRPT.
SRPT Growth Metrics
- Its 2 year net cashflow from operations growth rate is now at -214.62%.
- Its 4 year revenue growth rate is now at 1772.43%.
- Its 4 year price growth rate is now at 266.98%.
The table below shows SRPT's growth in key financial areas (numbers in millions of US dollars).
|Date||Revenue||Operating Cash Flow||Net Income to Common Stock|
SRPT's Quality FactorsThe “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
- SRPT has a Quality Grade of C, ranking ahead of 59.75% of graded US stocks.
- SRPT's asset turnover comes in at 0.231 -- ranking 185th of 682 Pharmaceutical Products stocks.
- ORMP, AGIO, and JAZZ are the stocks whose asset turnover ratios are most correlated with SRPT.
The table below shows SRPT's key quality metrics over time.
|Period||Asset Turnover||Gross Margin||ROIC|
SRPT Stock Price Chart Interactive Chart >
SRPT Price/Volume Stats
|Current price||$120.25||52-week high||$134.08|
|Prev. close||$122.36||52-week low||$61.28|
|Day high||$122.86||Avg. volume||1,026,247|
|50-day MA||$123.27||Dividend yield||N/A|
|200-day MA||$100.57||Market Cap||10.56B|
Sarepta Therapeutics, Inc. (SRPT) Company Bio
Sarepta Therapeutics is a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. The company was founded in 1980 and is based in Cambridge, Massachusetts.
Most Popular Stories View All
SRPT Latest News Stream
|Loading, please wait...|
SRPT Latest Social Stream
View Full SRPT Social Stream
Latest SRPT News From Around the Web
Below are the latest news stories about SAREPTA THERAPEUTICS INC that investors may wish to consider to help them evaluate SRPT as an investment opportunity.
The share price of Sarepta Therapeutics Inc. (NASDAQ:SRPT) rose to $124.47 per share on Thursday from $123.16. While Sarepta Therapeutics Inc. has overperformed by 1.06%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SRPT rose by 81.15%, with highs and lows ranging from $134.08 to $61.28, […]
These gene editing stocks are likely to deliver massive gains ahead in the fast-evolving biotech space
Although the health innovation space presents risks, the opportunities beckon a look at the biotech stocks that will make you rich in 10 years.
Trading Sarepta Therapeutics Inc. Com SRPT With Integrated Risk Controls
- The Company expects to exceed 2022 full-year guidance for net product revenues
SRPT Price Returns
Continue Researching SRPTWant to see what other sources are saying about Sarepta Therapeutics Inc's financials and stock price? Try the links below:
Sarepta Therapeutics Inc (SRPT) Stock Price | Nasdaq
Sarepta Therapeutics Inc (SRPT) Stock Quote, History and News - Yahoo Finance
Sarepta Therapeutics Inc (SRPT) Stock Price and Basic Information | MarketWatch